Health

Source link : https://newshealth.biz/health-news/complement-inhibitor-slowed-kidney-decline-in-iga-nephropathy/ Iptacopan significantly slowed kidney function decline over 24 months compared with placebo in adults with IgA nephropathy. The complement inhibitor was granted accelerated approved in 2024; continued approval was contingent on demonstrating slowed kidney decline. Fewer participants in the iptacopan group reached the composite kidney-failure endpoint. Iptacopan (Fabhalta) slowed kidney function decline in adults with […] […] More

Source link : https://newshealth.biz/health-news/hi-peitho-kicks-off-golden-era-in-pulmonary-embolism/ NEW ORLEANS — A major advance for the treatment of intermediate-risk pulmonary embolism (PE) arrived with HI-PEITHO’s landmark report on ultrasound-facilitated, catheter-directed thrombolysis (CDT). In this hard-to-treat group of acute PE patients, the composite endpoint of PE-related death, cardiorespiratory decompensation or collapse, or symptomatic recurrence of PE within 7 days significantly favored individuals who got […] […] More

Source link : https://newshealth.biz/health-news/pcsk9-drug-prevents-first-heart-events-in-diabetes-patients-without-atherosclerosis/ NEW ORLEANS — Evolocumab (Repatha) reduced risk of a first major cardiovascular (CV) event in patients with diabetes but no known atherosclerosis in a substudy of the VESALIUS-CV trial. The PCSK9 inhibitor cut relative risk by 31% compared with placebo whether looking at the composite of death from coronary heart disease, myocardial infarction (MI), or […] […] More

Source link : https://newshealth.biz/health-news/watchman-laa-occluder-bounces-back-as-alternative-to-oac-in-champion-af/ NEW ORLEANS — It may be reasonable for people with atrial fibrillation (Afib) to undergo percutaneous left atrial appendage (LAA) closure even if long-term anticoagulation is an alternative, according to the large CHAMPION-AF trial presented here. Three years after LAA closure with the Watchman FLX device, statistical criteria were met for the device’s non-inferiority to […] […] More

Source link : https://newshealth.biz/health-news/fibrinolytic-beats-current-standard-for-intermediate-risk-pe/ For intermediate-risk pulmonary embolism, a low-dose fibrinolysis strategy reduced PE-related events by half with no significant increase in bleeding vs standard therapy. Medscape Medical News Source link : https://www.medscape.com/viewarticle/fibrinolysis-treatment-validated-large-trial-acute-2026a10009im?src=rss Author : Publish date : 2026-03-28 21:20:00 Copyright for syndicated content belongs to the linked Source. The post Fibrinolytic Beats Current Standard for Intermediate-Risk PE first appeared […] More

Source link : https://newshealth.biz/health-news/quiz-time-can-radiologists-spot-ai-deepfakes/ The 24-hour news cycle is just as important to medicine as it is to politics, finance, or sports. At MedPage Today, new information is posted daily, but keeping up can be a challenge. As an aid for our readers, and for a little amusement, here is a 10-question quiz based on the news of the […] […] More

Source link : https://newshealth.biz/health-news/laac-an-alternative-for-noac-in-lower-risk-af-patients/ CHAMPION-AF finds left atrial appendage closure and anticoagulation therapy for atrial fibrillation about equal but raises doubts about whether the former is a true alternative. Medscape Medical News Source link : https://www.medscape.com/viewarticle/champion-af-trial-finds-laac-alternative-noac-lower-risk-2026a10009ij?src=rss Author : Publish date : 2026-03-28 19:51:00 Copyright for syndicated content belongs to the linked Source. The post LAAC an Alternative for NOAC in […] More

Source link : https://newshealth.biz/health-news/cooking-and-dementia-risk-high-dose-vs-standard-dose-flu-shot/ TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of Texas Tech Health El Paso, look at the top medical stories of the week. This week’s topics include cooking and dementia risk, replacing the aortic valve in […] […] More

Source link : https://newshealth.biz/health-news/we-have-a-substance-use-prevention-problem/ Every week in the pediatric emergency department, I watch the consequences of adolescent substance use arrive through our doors. Overdoses. Acute intoxication. Psychiatric crises triggered by substances that started as experimentation years earlier. And almost every time, somewhere in the history, there is a moment when prevention could have worked — and didn’t. We have […] […] More

Source link : https://newshealth.biz/health-news/roflumilast-promising-for-ad-in-children-down-to-age-3-mos/ Global assessment and itch/scratch scores highlight the effectiveness of topical roflumilast for treating atopic dermatitis in children 3 months to 2 years old, in a phase 2 study. Medscape Medical News Source link : https://www.medscape.com/viewarticle/roflumilast-shows-promise-treating-atopic-dermatitis-2026a10009ia?src=rss Author : Publish date : 2026-03-28 16:34:00 Copyright for syndicated content belongs to the linked Source. The post Roflumilast Promising for […] More

Source link : https://newshealth.biz/health-news/pupil-art-sessions-bring-joy-to-hospice/ The Hospice in the Weald in Pembury runs the sessions for people with life-limiting conditions. Source link : https://www.bbc.com/news/articles/c4gx92jedw2o?at_medium=RSS&at_campaign=rss Author : Publish date : 2026-03-28 16:06:00 Copyright for syndicated content belongs to the linked Source. The post Pupil art sessions ‘bring joy’ to hospice first appeared on News Health. —- Author : News Health Publish date […] More

Source link : https://newshealth.biz/health-news/ceragenin-coated-endotracheal-tubes-fail-to-reduce-ventilator-associated-pneumonia/ CHICAGO — Using endotracheal tubes (ETTs) coated with ceragenins did not reduce the incidence of ventilator-associated pneumonia (VAP) compared to standard subglottic suction ETTs, but mortality was lower with the ceragenin-coated ETTs, according to the CEASE VAP study. In the prospective, pragmatic crossover trial, VAP occurred in 19% of patients receiving ceragenin-coated (Cerashield) endotracheal tubes […] […] More